Drugs / MDX-1379
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00094653 | Sep 2004 → Aug 2009 | melanoma, metastatic neoplasm | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MDX-1379 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00094653 ↗ |
| Modality | Vaccine | “MDX-1379 (gp100) Melanoma Peptide Vaccine” NCT00094653 ↗ |